STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

08.07.2015 10:33

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ameriprise International Holdings GmbH, Zug, Switzerland, has notified us on 3 July 2015 pursuant to § 21 sec. 1 WpHG that on 29 June 2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, exceeded the threshold of 3% and amounted on that day to 4.87% (575,168 voting rights). Pursuant to § 22 para. 1 sent. 1 No. 6 WpHG, all voting rights are attributable to Threadneedle Investment Funds ICVC.

08.07.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at and

Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
End of Announcement DGAP News-Service